hioksizons 10 mg/30 mg/g ziede
as Ņižfarm pārstāvniecība, latvija - hydrocortisoni acetas, oxytetracyclini hydrochloridum - ziede - 10 mg/30 mg/g
doxitin 150 mg tabletes
vitabalans oy, finland - doksiciklīns - tablete - 150 mg
doxitin 100 mg tabletes
vitabalans oy, finland - doksiciklīns - tablete - 100 mg
rovamycine 3 milj.sv apvalkotās tabletes
sanofi winthrop industrie, france - spiramicīns - apvalkotā tablete - 3 miljoni sv
rovamycine 1,5 milj.sv apvalkotās tabletes
sanofi-aventis latvia, sia, latvija - spiramicīns - apvalkotā tablete - 1,5 miljoni sv
clarithromycin actavis 500 mg ilgstošās darbības tabletes
actavis group ptc ehf., iceland - klaritromicīns - ilgstošās darbības tabletes - 500 mg
clarithromycin ingen pharma 250 mg apvalkotās tabletes
ingen pharma, sia, latvia - klaritromicīns - apvalkotā tablete - 250 mg
clarithromycin ingen pharma 500 mg apvalkotās tabletes
ingen pharma, sia, latvia - klaritromicīns - apvalkotā tablete - 500 mg
bactox 500 mg cietās kapsulas
laboratoire innotech international sas, france - amoksicilīns - cietās kapsulas - 500 mg
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningīts, meningokoku - vakcīnas - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.